Spelling suggestions: "subject:"intestine"" "subject:"intestines""
391 |
Efeitos da sobrecarga de fósforo dietético na expressão dos cotransportadores NaP-IIb e PiT-1 em ratos controles e urêmicos / Phosphorus overload effects on NaP-IIb and PiT-1 cotransporters in control and uremic ratsTatiana Martins Aniteli 24 June 2015 (has links)
O fósforo é um dos minerais mais abundantes no corpo além de ser essencial para muitos processos biológicos. A homeostase do fósforo depende da absorção no intestino, da excreção renal, da remodelação óssea e de hormônios como o paratormônio, calcitriol e FGF-23. Nos pacientes com doença renal crônica, a excreção urinária de fósforo está comprometida levando à hiperfosfatemia, que contribui para o aumento da morbidade e mortalidade desses pacientes. A absorção intestinal de fósforo no intestino delgado, particularmente via cotransportadores NaP-IIb e PiT-1, é pouco estudada. O objetivo desse estudo foi avaliar os efeitos de dietas com diferentes concentrações de fósforo na expressão proteica e gênica dos cotransportadores NaP-IIb e PiT-1, bem como na apoptose dos enterócitos dos diferentes segmentos do intestino delgado de animais controles e urêmicos. Estudamos setenta e seis ratos Wistar machos, inicialmente divididos em dois grupos: controles (C) e urêmicos (Nx). Cada grupo foi subdividido em outros três, de acordo com a concentração de fósforo (P) na dieta: dieta Baixa (0,2%), dieta Padrão (0,54%) e dieta Alta (0,9%). Analisamos parâmetros bioquímicos (creatinina, P, Cai, PTH e FGF-23), a expressão proteica dos cotransportadores, através de Western Blotting, ELISA e imunofluorescência, a expressão gênica por PCR em tempo real e a apoptose dos enterócitos pela técnica TUNEL. Os resultados mostraram que os níveis séricos de creatinina, P, PTH e FGF-23 foram significativamente mais elevados nos animais Nx. Nos animais C com dieta baixa em P observamos aumento da expressão proteica do cotransportador NaP-IIb em todos os segmentos do intestino enquanto, no Nx Baixo, a expressão desse cotransportador foi menor somente no jejuno. Quanto ao PiT-1, sua expressão foi menor no íleo do grupo Nx Alto comparado ao seu respectivo controle. A expressão gênica do cotransportador NaP-IIb foi menor no jejuno do Nx Alto e maior no íleo desse mesmo grupo em relação aos seus respectivos controles. A expressão gênica do PiT-1 foi maior em todos os segmentos do grupo Nx Baixo em relação aos seus controles. Detectamos uma correlação direta entre a expressão gênica do NaP-IIb no jejuno com o fósforo sérico. A expressão gênica do PiT-1 no jejuno correlacionou-se com o fósforo sérico e no duodeno e jejuno, com os níveis séricos de FGF-23. No duodeno e no jejuno, a porcentagem de enterócitos apoptóticos foi maior nos animais Nx Alto comparados aos controles, particularmente no duodeno a porcentagem dessas células também foi maior no grupo Nx Baixo e controle padrão. Já no jejuno, tanto o grupo Nx baixo quanto no Nx Padrão observamos menos células apoptóticas que nos seus respectivos controles. Quando analisamos conjuntamente todos os segmentos intestinais o grupo Nx alto apresentou mais células apoptóticas que o controle e o oposto foi observado nos grupos Nx Baixo e Nx Padrão. Em conclusão, dietas com distintas concentrações de fósforo promovem modificações na expressão proteica e gênica dos cotransportadores NaP-IIb e PiT-1 no intestino delgado que não seguem um padrão uniforme. A sobrecarga de fósforo aumenta a porcentagem de enterócitos apoptóticos nos animais urêmicos / Phosphorus is one of the most abundant minerals in the body besides being essential for many biological processes. Phosphorus homeostasis depends on absorption in the small intestine, renal excretion, bone remodeling and hormones such as parathyroid hormone, calcitriol and FGF-23. In patients with chronic kidney disease phosphorus urinary excretion is compromised leading to hyperphosphatemia, which contributes to increased morbidity and mortality of these patients. Intestinal absorption of phosphorus in the small intestine, particularly of NaP-IIb and PiT-1 cotransporters is poorly studied. The aim of this study was to evaluate the effects of diets with different concentrations of phosphorus in protein expression and gene of NaP-IIb and PiT-1 cotransporters as well as in apoptosis of enterocytes of different segments of intestine in control and uremic animals. We studied seventy-six male Wistar rats initially divided into two groups: controls (C) and uremic (Nx). Each group was subdivided into three others, according to the phosphorus concentration in the diet: Low diet (0.2% P), Standard diet (0.54% P) and High diet (0.9% P). We analyzed biochemical parameters (creatinine, P, iCa, PTH and FGF-23), protein expression of cotransporters, using Western Blot, ELISA, immunofluorescence, real-time PCR and apoptosis of enterocytes using the TUNEL technique. Results showed that serum creatinine, P, PTH and FGF-23 were significantly higher in Nx animals. In C animals with a diet low in P we observed increase in protein expression of NaP-IIb cotransporter in all segments of the intestine while in low Nx expression of this cotransporter was lower only in jejunum. As for PiT-1 expression was lower in the ileum of the high Nx group compared to their respective control. Gene expression of NaP-IIb cotransporter was lower in the jejunum of high Nx and higher in the ileum of the same group as compared to their respective controls. PiT-1 gene expression was higher in all segments of the low Nx group compared to their controls. We detected a direct correlation between the gene expression of NaP-IIb in jejunum and serum phosphorus. Gene expression of PiT-1 correlated with serum phosphorus in the jejunum, and correlated with the serum levels of FGF-23 in the jejunum and duodenum. In the duodenum and jejunum the percentage of apoptotic enterocytes was higher in high Nx animals compared to controls; particularly in the duodenum the percentage of these cells was also higher in low Nx group and standard control. In the jejunum in both low Nx group and standard Nx we observed fewer apoptotic cells than in their respective controls. When we analyze all intestinal segments together the high Nx group had more apoptotic cells than the control, and the opposite was observed in the low Nx group and standard Nx group. In conclusion, diets with different phosphorus concentrations promote changes in protein expression and gene of NaP-IIb and PiT-1 cotransporters in the small intestine that do not follow a uniform pattern. Phosphorus overhead increases the percentage of apoptotic enterocytes in uremic animals
|
392 |
Modelo experimental de doença do enxerto versus hospedeiro após transplante de intestino delgado / Experimental model of graft versus host disease after small intestine transplantationFlávio Henrique Ferreira Galvao 10 February 1998 (has links)
A doença do enxerto versus hospedeiro (DEVH) é uma grave complicação do transplante de órgãos sólidos, com alta mortalidade. Seu estudo tem sido limitado pela carência de modelos experimentais apropriados. Descreve-se um modelo de DEVH baseado no aumento do quimerismo, sua evolução clínica, histopatológica, do número das células quiméricas, do perfil das citocinas e da tolerância imunológica. Ratos Lewis (LEW) foram submetidos a transplante simultâneo de intestino delgado e medula óssea provenientes de ratos ACI (grupo de estudo - E) ou LEW (grupo controle - C), tratados com FK-506 (1 mg/Kg/dia) entre o 0 e 13o PO, e uma dose semanal daí por diante. Os ratos foram divididos nos seguintes grupos: E1- 6 ratos sacrificados no 120o PO. E2- 8 ratos após apresentarem sinais clínicos graves de DEVH entre o 189o e o 271o PO. Como controle, ratos LEW foram receptores dos mesmos tipos de enxertos provenientes de ratos LEW, submetidos à mesma imunossupressão e foram assim divididos: C1- 6 ratos sacrificados no 120o PO, C2- 5 ratos sacrificados entre o 223o e o 270o PO. A citometria de fluxo foi realizada para quantificar a porcentagem das células linfóides de ACI doadores no sangue periférico nos E1, E2 em 6 períodos: 30o PO, 65o PO, 95o PO, 120o PO, 160o PO, 200o PO. Os animais foram examinados 2 vezes por semana à procura de sinais de DEVH (rash cutâneo, perda de peso, de pelo e hiperqueratose). No sacrifício dos animais do grupo E1 e C1, foram colhidas amostras de língua (LI), de linfonodos cervicais (LC), intestino delgado do receptor e do enxerto para análise das citocinas IL-2, IL-4, IL-6, IL-10, IFN-gama e TNF-alfa por meio da reação em cadeia da polimerase. Em todos os grupos foram também colhidas amostras destes órgãos para histopatologia e nos animais do grupo E2 linfonodos cervicais foram processados para análise da reatividade celular por meio da reação mista dos linfócitos (MLR). A evolução clínica e histopatológica foi graduada de 0 a 3 de acordo com a severidade dos sintomas e do infiltrado mononuclear das amostras. Os ratos dos grupos E1 e E2 iniciaram sinais da DEVH entre o 84o e 115o PO. Os ratos dos grupos C1 e C2 não apresentaram evidência de DEVH. Amostras de LI e LC dos ratos do grupo E1 apresentaram alterações histopatológicas grau 2 e do grupo E2 apresentaram alterações histopatológicas grau 3, respectivamente. Nenhuma alteração histopatológica foi encontrada nos ratos do grupo controle e em amostras do ID. Nenhuma alteração histopatológica foi encontrada no intestino delgado do receptor e do enxerto. O aumento da porcentagem de células do doador no sangue periférico do receptor foi progressivo chegando a 5,4±2.3% no 10o período, 21±4,6% no 3o período e 39,3±4% no 6o período. IL-2, IL-6, IL-10, IFN-gma e TNF-alfa estiveram aumentados em língua e IL-4, IL-6, IL-10, IFN-gama e TNF-alfa em linfonodos cervicais. Os linfócitos de ratos do grupo E2 mostraram hiporreatividade aos de ratos ACI e hiperreatividade aos de ratos PVG (terceira parte) denotando tolerância imunológica. Neste modelo experimental há uma inexorável evolução imunológica para DEVH; existe correlação direta entre o aumento do quimerismo em sangue periférico e da expressão de citocinas em língua e linfonodos cervicais e a severidade da DEVH, além da indução de tolerância imunológica do rato do grupo E2 quimérico ao rato ACI normal. / Graft-versus-host disease (GVHD) has been a major concern after small bowel transplantation (SBTX) and the lack of suitable experimental models has limited the study of GVHD after solid organ transplantation. Here we describe a re1evant experimental model of GVHD after fully allogeneic SBTX based on chimerism augmentation, its clinical and histophatological evolution, cytokine involvement, responsible donor cell and immunologic tolerance analysis. LEW rat recipients received orthotopic SBTX and simultaneous donor bone marrow cell infusion (250x106), from ACI rats (experimental group - E) or LEW (control group C). FK-506 was administered dayly at a dose of 1 mg/kg on day 0 to 13, then continued as a weekly injection of same dose until the experimental end point. The recipients were divided in the following groups: E1 - 6 rats sacrificed at 120° POD. E2 - 8 rats sacrificed with critical GVHD between DPO 189 to 271. LEW recipient of LEW grafts, under the same immunossupression were used as control and divided as: C1 - 6 rats sacrificed at POD 120; C2- 5 rats sacrificed between 223 and 270 POD the number of donor cell in the recipient circulation was determined by flowcytometry in 6 pos-operative time: 30, 65, 95, 120, 160, 200. The rats were analyzed twice a week for body weigh and searching for signs of GVHD (cutaneous rush, hiperkeratosis and loss of hair and body weigh). At the sacrificed, samples from tongue (TG), cervical lymph node (CLN), donor (SBD) and recipient (SBR) small bowel were taken from all animals for histophatology and from E1 and C1l animals for IL-2, IL-4, IL-6, IL-10, IFN-gama e TNF-alfa cytokines analysis using reverse transcription polymerase chain reaction. Samples from cervical lynph nodes of 5 animals from group E2 were used for mixed lymphocyte reaction for tolerance analysis. The clinical and histophatological evolution of the disease were evaluated from degree 0 to 3 according to the severity. GVHD in E1 and E2 animals started between 84 and 115 POD. Histophatological analysis of TG and CLN showed that E1 animals present GVHD grade 2 and E2 animals grade 3. The increase of donors cells in the recipient circulation was progressive and account for 5.4± 2.3% at POD 30, 21.4±4.6% at POD 95 and 39.3±4% at POD 200. IL-4, IL-6, IL-10, IFN-gama e TNF-alfa were upregulated in CLN and IL-2, IL-6, IL-10, IFN-gama e TNF-alfa were upregulated in TG when compared with the respective controls. The lymphocytes from E2 group showed hyporeactivety to lymphocytes of normal ACI and hypereactivety to those of PVG, meaning tolerance. No cytokines alteration was noted in SBD neither SBR. Animals from group C1 and C2 did not present any sign of disease. This result show that GVHD is a inexoravel evolution under the experimental conditions of this study and the evolution of the disease is near correlated with the augmentation of the donor cells in the recipient circulation and upregulation of cytokines gene expression in target organs. Tolerance to the same donor strain lynphocytes was also noted.
|
393 |
In vitro a ex vivo studium lékových interakcí antiretrovirálních látek na střevních ATP-vázajících lékových transportérech / In vitro and ex vivo study of drug-drug interactions of antiretrovirals on intestinal ATP-binding drug transportersJahodová, Michaela January 2017 (has links)
Charles University in Prague Faculty of Pharmacy in Hradec Králové Department of Pharmacology and Toxicology Student: Bc. Michaela Jahodová Supervisor: PharmDr. Lukáš Červený, Ph.D. Title of diploma thesis: In vitro and ex vivo study of drug-drug interactions of antiretrovirals on intestinal ATP-binding drug transporters The absorption of orally administered drugs takes place especially in the intestine, where it can affect by the activity of drug's ABC transporters located on the apical membrane of the intestinal epithelium. Study of drug interactions in intestinal ABC transporters is essential to ensure effective and safe pharmacotherapy. Testing of bi- directional transport on Caco-2 cells is generally the preferred method for in vitro evaluation of substrates and inhibitors of ABC transporters. Drawbacks of the Caco-2 model increase the need and necessity to introduce new models. A great potential is the involvement of ex vivo methodologies in the human or rat intestine. The aim of the work was to introduce an in vitro methodology using the Caco-2 cell monolayer and the ex vivo methodology of precision-cut rat intestinal slices. By the bi-directional transport method, we analyzed drug interactions of the model substrate P-gp and BCRP Rhodamine 123 (RHD123) and clinically-used tenofovir...
|
394 |
Impact de l'ivermectine sur les systèmes de détoxification des xénobiotiques : régulations chez l'hôte et chez le nématode / Impact of ivermectin on xenobiotic detoxification systems : regulations in host and nematodeAlbérich, Mélanie 16 December 2014 (has links)
Les infections par les nématodes gastro-intestinaux entrainent des baisses en productions animales et des pertes économiques majeures pour les éleveurs. Les lactones macrocycliques (LMs) sont parmi les antiparasitaires les plus utilisés dans la lutte contre les nématodes gastro-intestinaux en médecine vétérinaire. De part une utilisation intensive, des résistances aux LMs chez les parasites gastro-intestinaux se sont développées au sein des élevages du monde entier mettant en péril l'efficacité thérapeutique de ces molécules. Par ailleurs, le développement de nouveaux antiparasitaires est limité. Ainsi, un des enjeux pour assurer le contrôle de ces parasites est de ralentir les phénomènes de résistance aux LMs afin de prolonger leur efficacité. Le succès d'une telle stratégie repose sur les connaissances précises des mécanismes impliqués dans la résistance. Parmi eux, la modulation des systèmes de détoxification est décrite lors de phénomènes de résistance aux LMs. Au cours de ces travaux, nous avons étudiés la régulation des systèmes de détoxification, en réponse à l'ivermectine chez l'hôte. Nous avons montré, en comparaison à une administration unique, qu'une administration répétée d'ivermectine par voie orale chez la souris est responsable de l'induction de l'expression de certains gènes transporteurs ABC et cytochromes impliqués dans son métabolisme. Ceci entraîne, à la fois, une diminution de la concentration de la molécule parentale et une augmentation de la teneur de son métabolite principal dans le plasma et l'intestin. Ensuite, nous avons étudié l'implication des mécanismes de régulation des systèmes de détoxification, et notamment les récepteurs nucléaires, dans la tolérance à l'ivermectine chez le nématode C.elegans. Nous avons montré que le récepteur nucléaire nhr-a est important pour la tolérance et le développement de la résistance à l'ivermectine. Enfin, nous avons étudié l'impact d'inhibiteurs des transporteurs ABC sur l'efficacité de l'ivermectine. Nous avons mis en évidence la capacité de certains flavonoïdes et de l'ivermectine aglycone à potentialiser l'efficacité de l'ivermectine chez le nématode. Une exposition d'ivermectine induit la surexpression des systèmes de détoxification chez l'hôte. Ceci pourrait être la base des mécanismes moléculaires de la résistance chez le nématode. Cibler les systèmes de détoxification ou les mécanismes de résistance, par des inhibiteurs adaptés, représente une stratégie pertinente pour potentialiser l'efficacité de l'ivermectine. / Infections with gastrointestinal nematodes (GINs) in livestock leads to major losses in production and consequently impact economically farmers. Their intensive use has led to widespread anthelmintic resistance which is nowadays the main threat on the sustainable control of GINs in livestock. The development of new anthelmintic is limited due to the cost of such process. Then, the challenge remains in optimizing the use of existing molecules. Therefore, it is urgent to limit and control MLs resistance in order to extend their efficacy and to avoid therapeutic failure. Resistance mechanisms remain to be elucidated. In that context, we investigated regulatory mechanism of detoxification systems of ivermectin implicated in therapeutic efficacy in host and resistance development in nematode. Therapeutic combinations of ivermectin with flavonoïds have been evaluated to potentiate its efficacy in nematode. We showed that repeated oral administration of ivermectin induced gene expression encoding some ABC efflux transporters and cytochromes involved in its metabolism. Compared with single administration, repeated ivermectin administration lowered plasma, liver and intestine drug concentration, while increasing main metabolite content in plasma and intestine. We have also shown that nuclear receptor nhr-a was important for ivermectin tolerance and ivermectin development of resistance in C. elegans. Finally, we demonstrated the ability of the flavonoïd phloretin to potentiate ivermectin efficacy in the nematode C. elegans. Taken together, these data suggest that induction of detoxification systems impact on ivermectin distribution and targeting their regulation could be an appropriate strategy to potentiate ivermectin efficacy in host and to reverse resistance in nematode.
|
395 |
Molecular Identification and Functional Characteristics of Peptide Transporter 1 (PEPT1) in the Bonnethead Shark (Sphyrna tiburo)Hart, Hannah 01 January 2015 (has links)
Many elasmobranchs are considered top predators with worldwide distribution, and in general these fish play an important role in the transfer of energy from the lower to the upper trophic levels within the marine ecosystem. Despite this, little research has been done regarding the rates of prey ingestion, digestion, and the processes of energy and nutrient absorption. Specifically understudied is enzymatic digestion within the intestinal brush border, which functions to break down macromolecules into smaller subunits for luminal absorption across the gastrointestinal epithelium. Given their carnivorous diet, the present study sought to expand knowledge on nutrient intake in elasmobranchs by focusing on the uptake of products of protein metabolism. To accomplish this, sequence encoding Peptide Transporter 1 (PepT1), a protein found within the brush border membrane (BBM) of higher vertebrates that is responsible for the translocation and absorption of small peptides released during digestion by luminal and membrane-bound proteases, was molecularly identified in the bonnethead shark (Sphyrna tiburo) using degenerate primers based on conserved portions of known PEPT1 sequences from other vertebrates. Sequence encoding Peptide Transporter 2 (PepT2) was also isolated from the S. tiburo scroll valve intestine using the same methodology. PepT1 was then localized using immunocytochemistry with rabbit polyclonal anti-rat PEPT1 in the esophagus, stomach, duodenum, scroll valve intestine, rectum, and pancreas. Vesicle studies were used to identify the apparent affinity of the transporter, and to quantify the rate of uptake by its H+-dependent cotransporter properties, using 3H-glycylsarcosine as a model dipeptide. The results of this study provide insight into the rate and properties of food passage within S. tiburo, and can lead to future work on topics such as physiological regulation of protein metabolism and absorption and how it may vary in elasmobranchs that exhibit different feeding strategies.
|
396 |
Interactions fonctionnelles entre voies signalétiques intrinsèques et voie des hormones thyroïdiennes dans les cellules souches et progéniteurs de l'épithélium intestinal / Functional interactions between intrinsic pathways and thyroid hormone-dependent signalling in intestinal epithelium stem and progenitor cellsGodart, Matthias 20 September 2019 (has links)
Les hormones thyroïdiennes (HTs) contrôlent plusieurs aspects du développement et de l’homéostasie intestinale. Elles agissent via des récepteurs nucléaires (TRs), facteurs de transcription modulés par la T3. Le paradigme est la métamorphose des amphibiens où elles sont responsables du remodelage du tube digestif et de l’émergence des cellules souches (Ishizuya-Oka et al, 2009). Des études précédentes ont montré que les HTs jouent un rôle fondamental en régulant la balance entre prolifération et différenciation des précurseurs épithéliaux murins. Du point de vue moléculaire, le récepteur nucléaire TRα1 contrôle plusieurs gènes du cycle cellulaire/prolifération ainsi que les voies de signalisation Wnt et Notch (rev. in Sirakov et al, 2104; Skah et al, 2017). En accord avec ces fonctions, l’expression ciblée de TRα1 dans l’épithélium intestinal (souris vil-TRα1) est suffisante pour induire des cryptes aberrantes, hyper-prolifératives et confère une sensibilité accrue au programme de tumorigénèse intestinale dépendant de la mutation dans le gène Apc (vil-TRα1/Apc+/1638N mice) (Kress et al, 2010). Le but de mon travail a été d’étudier le contrôle des cellules souches intestinales, dépendant des HTs/TRs. En effet, j’ai utilisé des souris Lgr5-EGFP-ires-CreERT2 permettant de traquer, trier et cibler les cellules souches (Barker et al, 2007) que j’ai croisées avec le modèle murin inductible au tamoxifène TRα1-LOF (Loss-of-function) (Quignodon et al, 2007). J’ai étudié les effets de l’altération de la voie HTs/TRα1 in vivo et dans des organoïdes intestinaux (ex vivo). Nos résultats indiquent que les HTs et la modulation de l’expression ou de l’activité de TRα1 affectent rapidement et fortement les cellules souches intestinales. Ce travail ouvre de nouvelles perspectives dans l’étude des signaux dépendants des HTs/ TRα1 dans la physiopathologie des cellules souches intestinales / Thyroid hormones (THs) control several aspects of gut development and homeostasis. They act through the thyroid hormone nuclear receptors (TRs) that are T3-modulated transcription factors. The paradigm is the amphibian metamorphosis, where they are responsible for gut remodeling and emergence of the stem cells (Ishizuya-Oka et al, 2009). In previous studies we showed that THs play a fundamental role in regulating the balance between cell proliferation and cell differentiation of the murine intestinal epithelial precursors. From a molecular point of view the nuclear receptor TRα1 controls several proliferation/cell-cycle genes as well as the Wnt and Notch pathways (rev. in Sirakov et al, 2104; Skah et al, 2017). In accordance with these functions, targeted expression of TRα1 in the intestinal epithelium (vil-TRα1 mice) is sufficient to induce aberrant and hyper-proliferative crypts and confers increased susceptibility to Apc-mutation dependent intestinal tumorigenic program (vil-TRα1/Apc+/1638N mice) (Kress et al, 2010). The aim of my work was to study TH- and TRα1-dependent control of intestinal stem cells. Indeed, I used the Lgr5-EGFP-ires-CreERT2 mice enable tracking, sorting and targeting the stem cells (Barker et al, 2007) crossed with tamoxifen inducible TRα1 loss-of-function (Quignodon et al, 2007) mouse model (TRα1-LOF). I studied the effect of TH/TRα1 alteration in vivo and in intestinal organoids (ex vivo). In conclusion, our results indicate that HTs and modulating TRα1 expression or activity have a rapid and strong effect on the intestinal stem cells. This work opens a new perspective in the study of TH/TRα1-dependent signal on the physiopathology of the intestinal stem cells
|
397 |
Consequences of Dietary Fibers and their Proportion on the Fermentation of Dietary Protein by Human Gut MicrobiotaRachel M. Jackson (5930684) 05 December 2019
In the human gut, bacterial fermentation of dietary fibers and proteins produces metabolites, primarily as short-chain fatty acids (SCFA), that are highly beneficial for host health. However, unlike dietary fiber, bacterial fermentation of protein additionally generates potentially toxic substances such as ammonia, hydrogen sulfide, amines, and indoles. It is believed that most gut bacteria favor utilization of dietary fiber over that of protein for energy. Therefore, when fermentable dietary fiber is readily available to colonic bacteria, protein fermentation, and its subsequent potentially toxic metabolites, remains relatively low. Dietary intake primarily determines the quantity of dietary fiber and protein substrate available to the gut microbiota and the resulting profile of metabolites produced. Increased protein consumption is associated with deleterious health outcomes such as higher risk of colorectal cancer and type II diabetes. Conversely, diets following US dietary recommendations are high in fiber, which promote a healthy microbiome and are protective against disease. Diets following the recommendation are also moderate in protein intake so that, ultimately, far more fiber than protein is available for colonic bacterial fermentation. On the contrary, dietary fiber intake is chronically low in a standard Western diet, while protein consumption is above dietary recommendations, which results in nearly equal amounts of dietary fiber and protein available for gut microbial fermentation. Furthermore, the popularity of high-protein diets for athletes, as well as that of high-protein low-carbohydrate diets for weight loss, may flip fiber and protein substrate proportions upside down, resulting in more protein than fiber available in the gut for fermentation. The objective of this study was to elucidate how substrate ratios in protein-fiber mixtures affect protein fermentation and metabolites, as well as examine the degree to which fiber source may influence these outcomes. Each dietary fiber source [fructooligosaccharides (FOS), apple pectin (Pectin), a wheat bran and raw potato starch mixture (WB+PS), and an even mixture of the three aforementioned fibers (Even Mix)] and protein were combined in three ratios and provided as substrate for in vitro fecal fermentation to understand how low, medium, and high fiber inclusion levels influence fermentation outcomes. They were compared to 100% protein and fiber (each different fiber) controls. Branched-chain fatty acids (BCFAs), metabolites produced exclusively from protein fermentation, were used as a measure of protein fermentation; the data were normalized based on the initial quantity of protein within the substrate. In protein-fiber substrate mixtures, only FOS and Even Mix inhibited BCFAs (mM/g protein basis) and only when they made up at least half of the substrate. Unexpectedly, the rate of protein fermentation was increased when the protein-fiber substrate contained 25% WB+PS fiber, possibly due to the starch component of the fiber. There was evidence that when pH drops during fermentation, as was the case for protein-FOS mixtures, it played a significant role in suppressing protein fermentation. Ammonia production was not largely affected by increasing the proportion of dietary fiber. A significant reduction did not occur until FOS made up at least 50% of the protein-fiber substrate; for Pectin, WB+PS, and Even Mix fibers, 75% inclusion was required for a significant decrease in ammonia. Interestingly, protein was butyrogenic. Protein as the sole substrate produced more butyrate than either Pectin or Even Mix as the sole substrates, and in fact, addition of Pectin to protein significantly reduced butyrate concentrations. However, the possible benefits of butyrate produced via protein fermentation needs to be tempered by the production of potentially toxic compounds and the association between protein fermentation and colorectal cancer. Overall, the thesis findings showed protein fermentation to be relatively stable and not easily influenced by increasing the availability of dietary fiber, and no clear evidence of microbial preference for carbohydrates over protein was found.
|
398 |
Gut Pathophysiology in Mouse Models of Social Behavior DeficitsScott, Kyla 01 May 2020 (has links)
Autism spectrum disorders (ASD) encompass neurodevelopment disorders characterized by atypical patterns of development that impact multiple areas of functioning beginning in early childhood. The etiology of ASD is unknown and there are currently no preventative treatment options. Gastrointestinal symptoms are commonly associated comorbidities. The microbiota-gut-brain axis is a multidirectional communication chain that connects the central and enteric nervous system that relates brain function to peripheral intestinal functions. Changes within this axis have been postulated in ASD. For example, the “leaky gut theory” proposes that chronic inflammation is linked to alterations in the bacterial profiles of the gut microbiome and subsequent shifts in the amount and type of short-chain fatty acids produced can affect downstream neuronal development. Short-chain fatty acids are signaling molecules produced by bacteria that can trigger nerve afferents in the gut. Dysbiosis causes altered signaling patterns that can be identified by altered intestinal morphology. In this study, C57BL/6J control mice and three mouse models of social behavioral deficits were used to investigate markers of intestinal pathophysiology. Fecal and intestinal samples were collected from adult wild type control mice and the social deficit groups of BTBR genetic knockout mice, C57BL/6J mice injected with valproic acid, and C57BL/6J mice injected with polyinosinic–polycytidylic acid. Short-chain fatty acid profiles that included acetic, propionic, isobutyric, butyric, isovaleric, and valeric acids were obtained from fecal samples to determine differences between the models and control mice. The profiles of the BTBR genetic knockout and valproic acid models were found to be significantly different from control mice. Additionally, postmortem intestinal ileum samples underwent hematoxylin and eosin identification procedures to determine the thickness of the tunica muscularis and tunica mucosa. The thickness of the tunica muscularis was reduced in the valproic acid group compared to the wild type control mice in early stages of development (p=0.0279). This research may illuminate developmental cues that attribute to autism spectrum disorders and may provide markers to assess future therapeutic treatments.
|
399 |
Remodelling of the F-actin Cytoskeleton of Polarized Epithelial Cells by the Type 3 Secretion System-1 Effector Proteins of Salmonella enterica sv. TyphimuriumFelipe-López, Alfonso 30 November 2015 (has links)
Darmepithelzellen entwickeln eine spezielle apikale Oberfläche zur Aufnahme von Nährstoffen aus dem Darminhalt. Diese Oberfläche besteht aus F-Aktin Protrusionen und werden als Mikrovilli (MV) bezeichnet. MV regulieren die kommensalen Bakterien und schützen die inneren Gewebe gegen den Angriff pathogener Mikroorganismen. Dennoch kann das Enteropathogen Salmonella enterica (Salmonella) die MV auslöschen und zerstört durch sein Typ-3-Sekretionssystem und dessen sekretierte Virulenzsproteine die Epithelschicht. Diese Virulenzproteine werden in das Zytoplasma der Wirtzellen injiziert und führen während des Eindringens von Salmonella zur F-Aktin Umlagerung. Durch Untersuchungen des Einflusses einiger T3SS-1 Effektorproteine auf die Zerstörung der MV konnte nachgewiesen werden, dass allein die Translokation von SopE die MV-Auslöschung verursachte und ausreichend für die Wiederherstellung der Invasion war. Echtzeitlebend-zellmikroskopie zeigte, dass MV ausgelöscht werden während Membranausstülpungen (Ruffles) gebildet werden. Diese Ruffle-Bildung vereinfachte ein paralleles Eindringen nicht-invadierender Stämme von Salmonella. Es konnte beobachtet werden, dass die Ausschaltung von Villin und Myosin 1a durch shRNA in C2BBe1 Zellen die Invasionsrate von Salmonella ermäßigte. Darüber hinaus wurde Ezrin zu den intrazellulären Bakterien aber nicht zur apikalen Seite rekrutiert. Außerdem verhinderte die durch das SopE verursachte Umlagerung des F-Aktins, welche die MV-Auflösung zur Folge hatte, die Makropinozytose der infizierten Zellen. Es lässt sich daraus schließen, dass die Zerstörung der MV für eine effiziente Invasion von Salmonella nötig ist. Die F-Aktin Umlagerung begünstigt zudem das Eindringen von nicht-invadierenden Bakterien. Des Weiteren benötigt Salmonella MV-Proteine zur F-Aktin Polymerisierung und Invasion in polarisierten Epithelzellen, was die Makropinozytose der Zellen beeinträchtigt. Möglicherweise tragen diese Phänotypen zur Infektion in vivo bei und verursachen das klinische Bild des Durchfalls.
|
400 |
Defining the Gut-Mammary Gland-Secretory IgA Axis in Porcine Epidemic Diarrhea Virus Infected Gilts and its Impact on Lactogenic Immune Protection of Neonatal Suckling PigletsLangel, Stephanie Mary Neal January 2018 (has links)
No description available.
|
Page generated in 0.0768 seconds